Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic study of topical omiganan with or without imiquimod in healthy volunteers
2016-004702-34Phase 2Completed
- Sponsor
- Biofrontera
- Start
- Jan 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of omiganan in dermatitis, sponsored by Biofrontera. Started Jan 2017; status: completed.
02
Drugs
omiganan
03
Conditions
dermatitis
Beyond the preview
Go deeper on 2016-004702-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004702-34.